EP. 5: Clinical Trials With BTK Inhibitors in Chronic Lymphocytic Leukemia
February 3rd 2021
Dr Brown provides a brief overview of data available that support the use of Bruton’s tyrosine kinase inhibitors in treating chronic lymphocytic leukemia; Dr Stilgenbauer comments on mitigating and managing adverse effects in the treatment of chronic lymphocytic leukemia.